Integrated Biomedical Informatics for Managing Cerebral Aneurysms

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to create a comprehensive database specifically for intracranial aneurysms by collecting clinical histories, imaging data, and biological samples. It will evaluate risk markers for aneurysm formation and rupture, as well as prognostic factors for various management strategies. Participants include patients with diagnosed aneurysms, healthy volunteers, and family members of affected individuals. The data collected will help inform patient-specific management protocols and improve understanding of the condition.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* able to provide consent or, in the event that a patient is incapable of providing consent, that a person is legally authorized to do so on behalf of the patient according to legal and ethical requirements of the country where the clinical centre is located.

Patients:

* must have an angiographically proven intracranial aneurysm (MRA\< CTA\< DSA accepted).The determination of SAH requires the presence of a subarachnoid haemorrhage be verified on CT or by lumbar puncture.

MRA: Magnetic Resonance Angiography CTA: Computed Tomography Angiography DSA: Digital Subtracted Angiography

Exclusion Criteria:

* failure of a candidate to contribute clinical data,
* refusal to provide informed consent.

Where it's running

• University of California
  San Francisco, California, United States Recruiting
• University of Cincinnati College of Medicine
  Cincinnati, Ohio, United States Recruiting
• University of Virginia
  Virginia Beach, Virginia, United States Recruiting
• Montreal Neurological Institute and Hospital, McGill University
  Montreal, Canada Recruiting
• Helsinki University Central Hospital
  Helsinki, Finland Recruiting
• Kuopio University Hospital
  Kuopio, Finland Recruiting

Study contacts

• Principal investigator: Philippe Bijlenga, PD MD PhD — Geneva University
• Study coordinator: Sven Hirsch, Dr
• Email: hirc@zhaw.ch
• Phone: +41 58 934 54 44

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Flow Diverter Stent for Intracranial Aneurysm in China

  This study tests a novel flow diverter stent to treat intracranial aneurysms in adults and follows patients through treatment and follow-up.

  Recruiting Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT07821957

• Real-World Experience With the WEB Device for Intracranial Aneurysms

  This study tests how well the Woven EndoBridge device works in routine treatment of intracranial aneurysms in China across multiple centers.

  Recruiting Xuanwu Hospital, Beijing · Beijing · NCT07620626

• Choydar flow-directed mesh stent for unruptured brain aneurysms

  This trial tests the Choydar flow-directed mesh stent to see if it is safe and works for people with unruptured intracranial aneurysms in the internal carotid or vertebral arteries.

  Recruiting at 8 sites Johnson & Johnson Medical (Shanghai) Ltd. · Chenzhou and 7 other locations · NCT07228312

• Pivotal test of the Silk Vista Baby Flow Diverter for unruptured brain aneurysms

  This study tests whether the Silk Vista Baby flow diverter can safely and effectively treat a single unruptured intracranial aneurysm in adults 22–80 years old.

  Recruiting at 6 sites Balt USA · Thousand Oaks, California and 5 other locations · NCT07225075

• Pipeline Vantage post-approval safety and outcomes for intracranial aneurysm treatment

  This project will test whether the Pipeline Vantage embolization device with Shield Technology is safe and effective for adults treated for intracranial aneurysms.

  Recruiting at 10 sites Medtronic Neurovascular Clinical Affairs · Jacksonville, Florida and 9 other locations · NCT06604884

• Improving brain intervention planning using vascular mapping

  This study is testing new ways to plan brain surgeries for aneurysms and AVMs to make them safer and more effective by using advanced mapping and computer models.

  Recruiting University Hospital, Ghent · Ghent · NCT06588543

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.